سعر ميسالاجيد 400مجم 10 اقراص 2026

Mesalazine 400 mg delayed-release tablets, 10 delayed-release tablets.

• Known or suspected hypersensitivity to salicylates, aminosalicylates or any ingredient.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Renal impairment (including minimal change disease, interstitial nephritis and renal failure) has been reported; evaluate renal function before and periodically during therapy.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Mesalamine-induced acute intolerance syndrome (cramping, abdominal pain, bloody diarrhoea, sometimes fever, headache, rash) may mimic a colitis flare; discontinue if suspected.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hypersensitivity reactions with internal organ involvement (myocarditis, pericarditis, nephritis, hepatitis, pneumonitis, blood abnormalities).International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Hepatic failure has been reported in patients with pre-existing liver disease.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Severe cutaneous adverse reactions (SJS, TEN, DRESS, AGEP); discontinue at first signs.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Photosensitivity, especially with pre-existing atopic dermatitis or eczema.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Nephrolithiasis (including radiolucent mesalamine stones); ensure adequate fluid intake.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Nephrotoxic agents including NSAIDsMay increase the risk of nephrotoxicity; monitor renal function.DailyMed (US National Library of Medicine)
• Azathioprine or 6-mercaptopurineMay increase the risk of blood disorders and bone marrow failure; monitor blood counts.DailyMed (US National Library of Medicine)

• Limited published human data show no increase in the overall rate of congenital malformations; some data show more preterm birth, stillbirth and low birth weight, outcomes also associated with active IBD.International label, equivalent formulation · DailyMed (US National Library of Medicine)
• Mesalamine and its N-acetyl metabolite are present in human milk at low concentrations.International label, equivalent formulation · DailyMed (US National Library of Medicine)

• Evaluate renal function before starting and periodically during treatment.International label, equivalent formulation · DailyMed (US National Library of Medicine)

English text not available for this section.